Bill Carroll is a consultant neurologist in the Department of Neurology and Neurophysiology at the Sir Charles Gairdner Hospital in Perth, Western Australia.
Currently, Bill Carroll is Chair of the MS Research Australia International Research Review Board, and a member of the International Progressive MS Alliance Scientific Steering Committee. Professor Carroll is also engaged as the Asia Pacific editor of the Multiple Sclerosis Journal, and the First Vice President of the World Federation of Neurology and foundation, and Vice President of the Pan Asian Committee for Research and Treatment of MS (PACTRIMS). Professor Carroll’s principal research activity has been in demyelinating disease, both multiple sclerosis and of the biology of demyelination and remyelination in experimental optic neuropathy.
Previously, Bill Carroll was Chair of the MS Research Australia Research Management Council, and previous President of the Australian and New Zealand Association of Neurologists and the XV111 World Congress of Neurology 2005.
Trevor Kilpatrick is a Professor of Neurology and Director of the Melbourne Neuroscience Institute at The University of Melbourne. He is the leader of the MS Division at the Florey Institute of Neuroscience and Mental Health, and is a neurologist and Head of the MS Unit at the Royal Melbourne Hospital.
Professor Kilpatrick graduated with a Bachelor of Medicine and a Bachelor of Surgery from the University of Melbourne in 1982, and then went on to specialise in neurology. He undertook graduate studies at The University of Melbourne and gained a Doctor of Philosophy in 1993. Following his Doctor of Philosophy, various appointments at The Salk Institute for Biological Studies (La Jolla, USA), the Institute of Neurology (London, UK) and The National Hospital and Moorfields Eye Hospital (London, UK) followed. He returned to Melbourne as the Viertel Senior Medical Research Fellow at the Walter & Eliza Hall Institute for Medical Research and as the Head of the Melbourne MS Research Unit at the Royal Melbourne Hospital.
Professor Kilpatrick has published widely including publications in Nature, Nature genetics and Nature Medicine. His research interests include the neurobiology of multiple sclerosis, neural precursor cell biology and the study of genetic and environmental factors that contribute to MS.
Gavin Giovannoni is the Chair of Neurology at the Blizard Institute Barts, Chair at The London School of Medicine and Dentistry, and Chair at the Neuroscience and Trauma Centre Lead in the Blizard Institute.
Professor Giovannoni undertook undergraduate medical training at the University of the Witwatersrand in South Africa. He moved to London in 1993 to complete a PhD at the Institute of Neurology, Queen Square. In 2006, Professor Giovannoni was appointed to the Chair of Neurology, Barts and The London School of Medicine and Dentistry.
His clinical interests focus on multiple sclerosis and other inflammatory disorders of the central nervous system, with a particular interest in clinical issues related to optimising MS disease modifying therapies.
Richard Ransohoff is the Senior Research Fellow in Neuroimmunology at Biogen Idec. He is a leading Neuroimmunologist, who has served on numerous scientific advisory and editorial boards. Professor Ransohoff currently sits on the National Multiple Sclerosis Society’s (NMSS) Medical Advisory Board.
Previously, he was engaged as the Director of the Neuroinflammation Research Center in the Department of Neurosciences of Lerner Research Institute at the Cleveland Clinic, was a Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, and Staff Neurologist in the Mellen Center for Multiple Sclerosis Treatment and Research at the Cleveland Clinic. He is also a member of the American Academy of Neurology, the American Neurological Association, the American Association of Physicians and the American Association for the Advancement of Science.
Professor Ransohoff’s extensive body of research, encompasses more than 300 publications across the fields of neurology and neuroimmunology. As a physician scientist, he has been continuously named to the “Best doctors in America”, for his expertise in the clinical care of patients with MS. Professor Ransohoff’s research has focused on the functions of chemokines and chemokine receptors in the development and pathology of the central nervous system.
In 2012, Professor Ransohoff received the John Dystel Award from the NMSS and American Academy of Neurology for multiple sclerosis research, followed by his M.D. from Case Western Reserve University School of Medicine.